Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylene Chloride SCHEMBL2391146 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 | |
| Methylene Chloride SCHEMBL2456472 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 | |
| Methylene Chloride SCHEMBL6704394 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 | |
| Methylene Chloride SCHEMBL861591 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 | |
| Methylene Chloride SCHEMBL4304807 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 | |
| Methylene Chloride SCHEMBL3630221 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 | |
| Methylene Chloride SCHEMBL7695098 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 | |
| Methylene Chloride SCHEMBL5133360 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 | |
| Methylene Chloride SCHEMBL1395290 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 | |
| Methylene Chloride SCHEMBL5091282 | 1.00 | ALDH1A1 (0.48) | ALDH1A1TDP1TRPA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118339171-A | Novel method for producing compound, novel compound, and metal catalyst | 国立研究开发法人科学技术振兴机构 | 2024-07-12 | — | — | CN | disclosed |
| EP-4385994-A1 | NOVEL METHOD FOR PRODUCING COMPOUND, NOVEL COMPOUND, AND METAL CATALYST | Japan Science and Technology Agency (JP) | 2024-06-19 | — | — | EP | disclosed |
| WO-2023017841-A1 | NOVEL METHOD FOR PRODUCING COMPOUND, NOVEL COMPOUND, AND METAL CATALYST | 国立研究開発法人科学技術振興機構 | 2023-02-16 | — | — | WO | disclosed |
| US-7608718-B2 | 4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity | SOLVAY PHARMACEUTICALS B.V. (NL) | 2009-10-27 | — | — | US | disclosed |
| US-20070259884-A1 | 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity | SOLVAY PHARMACEUTICALS B.V. | 2007-11-08 | — | — | US | disclosed |
| US-6974810-B2 | cannabinoid (cb1); treating disorders involving cannabinoid neurotransmission | SOLVAY PHARMACEUTICALS B.V. (NL) | 2005-12-13 | — | — | US | disclosed |
| CN-1529595-A | 4, 5-2H-1H-pyrazole derivatives having potent CB 1-antagonistic activity | ������ҩ������˾ | 2004-09-15 | — | — | CN | disclosed |
| EP-1429762-A1 | 4,5-DIHYDRO-1H-PYRAZOLE DERIVATIVES HAVING POTENT CB1-ANTAGONISTIC ACTIVITY | Solvay Pharmaceuticals B.V. (NL) | 2004-06-23 | — | — | EP | disclosed |
| US-20040106800-A1 | 4,5-Dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity | ABBVIE B.V. (NL) | 2004-06-03 | — | — | US | disclosed |
| WO-2003026648-A1 | 4,5-DIHYDRO-1H-PYRAZOLE DERIVATIVES HAVING POTENT CB1-ANTAGONISTIC ACTIVITY | SOLVAY PHARMACEUTICALS B.V. (NL) | 2003-04-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070259884-A1 | 4,5-Dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity | CNR1, CNR2, GPR55 | ALDH1A1 1410/4885TDP1 4634/4885TRPA1 250/4885 |
| US-20040106800-A1 | 4,5-Dihydro-1h-pyrazole derivatives having potent cb1-antagonistic activity | CNR1, CNR2, FAAH | ALDH1A1 996/4885TDP1 4313/4885TRPA1 242/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.